The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis

Reproductive Toxicology

Volumn 33, Issue 1, 2012, Pages 106-115

  López Casas, Pedro P ^a,e   Mizrak, Sefika C ^b,c   López Fernández, Luis A ^d   Paz, María ^a   De Rooij, Dirk G ^b,c   Del Mazo, Jesús ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e Structural Biology and Biocomputing Programme   (Spain)

Author keywords

17 Estradiol; Bisphenol A; DNA microarrays; Endocrine disruptor; Gene expression profile; Lindane; Mono ethylhexyl phthalate; Testis; Zearalenone

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DRINKING WATER; ESTRADIOL; LINDANE; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; TRANSCRIPTOME; ZEARALENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; TESTIS DEVELOPMENT;

ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; APOPTOSIS; CLUSTER ANALYSIS; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MALE; MATERNAL EXPOSURE; MEIOSIS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PREGNANCY; SPERMATIDS; TESTIS; TOXICITY TESTS;

MUS;

EID: 84856713159     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.12.012     Document Type: Article

References (84)

1. Woodruff T.J., Carlson A., Schwartz J.M., Giudice L.C. Proceedings of the summit on environmental challenges to reproductive health and fertility: executive summary. Fertil Steril 2008, 89:281-300.
2. Sharpe R.M., Irvine D.S. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health. BMJ 2004, 328:447-451.
3. Sharpe R.M. Environmental/lifestyle effects on spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010, 365:1697-1712.
4. Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., Guillette L.J., et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996, 104(Suppl. 4):741-803.
5. Toppari J., Virtanen H.E., Main K.M., Skakkebaek N.E. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol 2010, 88:910-919.
6. Singleton D.W., Khan S.A. Xenoestrogen exposure and mechanisms of endocrine disruption. Front Biosci 2003, 8:s110-s118.
7. European-Food-Safety-Authority Scientific report of the endocrine active substances task force. EFSA J 2010, 8.
8. Sharpe R.M., Skakkebaek N.E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 1993, 341:1392-1395.
9. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001, 16:972-978.
10. Asklund C., Jorgensen N., Kold Jensen T., Skakkebaek N.E. Biology and epidemiology of testicular dysgenesis syndrome. BJU Int 2004, 93(Suppl. 3):6-11.
11. Kristensen D.M., Sonne S.B., Ottesen A.M., Perrett R.M., Nielsen J.E., Almstrup K., et al. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol 2008, 288:111-118.
12. Guillette L.J. Endocrine disrupting contaminants - beyond the dogma. Environ Health Perspect 2006, 114(Suppl. 1):9-12.
13. Sharpe R.M., Skakkebaek N.E. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 2008, 89:e33-e38.
14. Bernhoft A., Behrens G.H., Ingebrigtsen K., Langseth W., Berndt S., Haugen T.B., et al. Placental transfer of the estrogenic mycotoxin zearalenone in rats. Reprod Toxicol 2001, 15:545-550.
15. Ema M., Miyawaki E. Effects of monobutyl phthalate on reproductive function in pregnant and pseudopregnant rats. Reprod Toxicol 2001, 15:261-267.
16. Hong E.J., Choi K.C., Jeung E.B. Maternal-fetal transfer of endocrine disruptors in the induction of Calbindin-D9k mRNA and protein during pregnancy in rat model. Mol Cell Endocrinol 2003, 212:63-72.
17. Fernandez M.F., Olmos B., Granada A., Lopez-Espinosa M.J., Molina-Molina J.M., Fernandez J.M., et al. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environ Health Perspect 2007, 115(Suppl. 1):8-14.
18. Mose T., Mortensen G.K., Hedegaard M., Knudsen L.E. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol 2007, 23:83-91.
19. Main K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 2006, 114:270-276.
20. Frederiksen H., Skakkebaek N.E., Andersson A.M. Metabolism of phthalates in humans. Mol Nutr Food Res 2007, 51:899-911.
21. Main K.M., Skakkebaek N.E., Virtanen H.E., Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010, 24:279-289.
22. CDC (Centers for Disease Control and Prevention) Third national report on human exposure to environmental chemicals 2005, Centers for Disease Control and Prevention, Atlanta, GA.
23. Turek P.J. Does the male infertility clinical evaluation adequately assess toxicologic exposures?. Fertil Steril 2008, 89:e69.
24. Edwards T.M., Myers J.P. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 2007, 115:1264-1270.
25. Delbes G., Levacher C., Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction 2006, 132:527-538.
26. Gray L.E., Ostby J., Furr J., Wolf C.J., Lambright C., Parks L., et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Hum Reprod Update 2001, 7:248-264.
27. Wilson V.S., Blystone C.R., Hotchkiss A.K., Rider C.V., Gray L.E. Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development. Int J Androl 2008, 31:178-187.
28. Borch J., Metzdorff S.B., Vinggaard A.M., Brokken L., Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology 2006, 223:144-155.
29. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
30. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30:75-95.
31. Maranghi F., Rescia M., Macri C., Di Consiglio E., De Angelis G., Testai E., et al. Lindane may modulate the female reproductive development through the interaction with ER-beta: an in vivo-in vitro approach. Chem Biol Interact 2007, 169:1-14.
32. Fisher J.S. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction 2004, 127:305-315.
33. Lehraiki A., Racine C., Krust A., Habert R., Levacher C. Phthalates impair germ cell number in the mouse fetal testis by an androgen- and estrogen-independent mechanism. Toxicol Sci 2009, 112:372-382.
34. Kim I.H., Son H.Y., Cho S.W., Ha C.S., Kang B.H. Zearalenone induces male germ cell apoptosis in rats. Toxicol Lett 2003, 138:185-192.
35. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., Stromberg A.J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 2003, 4:26.
36. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002, 94:513-521.
37. Ge X., Yamamoto S., Tsutsumi S., Midorikawa Y., Ihara S., Wang S.M., et al. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005, 86:127-141.
38. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15.
39. Fleischer A., Duhamel M., Lopez-Fernandez L.A., Munoz M., Rebollo M.P., Alvarez-Franco F., et al. Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis. Immunol Lett 2007, 112:9-29.
40. Rubio D., Garcia S., Paz M.F., De la Cueva T., Lopez-Fernandez L.A., Lloyd A.C., et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS ONE 2008, 3:e1398.
41. Guerra S., Gonzalez J.M., Climent N., Reyburn H., Lopez-Fernandez L.A., Najera J.L., et al. Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS. J Virol 2010, 84:8141-8152.
42. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., et al. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucleic Acids Res 2007, 35:D760-D765.
43. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371.
44. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C., et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-87.
45. Gatta V., Raicu F., Ferlin A., Antonucci I., Scioletti A.P., Garolla A., et al. Testis transcriptome analysis in male infertility: new insight on the pathogenesis of oligo-azoospermia in cases with and without AZFc microdeletion. BMC Genomics 2010, 11:401.
46. Herrero J., Diaz-Uriarte R., Dopazo J. Gene expression data preprocessing. Bioinformatics 2003, 19:655-656.
47. Vaquerizas J.M., Conde L., Yankilevich P., Cabezon A., Minguez P., Diaz-Uriarte R., et al. GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res 2005, 33:W616-W620.
48. de Hoon M.J., Imoto S., Nolan J., Miyano S. Open source clustering software. Bioinformatics 2004, 20:1453-1454.
49. Saldanha A.J. Java Treeview - extensible visualization of microarray data. Bioinformatics 2004, 20:3246-3248.
50. Guo L., Lobenhofer E.K., Wang C., Shippy R., Harris S.C., Zhang L., et al. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 2006, 24:1162-1169.
51. Shima J.E., McLean D.J., McCarrey J.R., Griswold M.D. The murine testicular transcriptome: characterizing gene expression in the testis during the progression of spermatogenesis. Biol Reprod 2004, 71:319-330.
52. Kanamori-Katayama M., Katayama S., Suzuki H., Hayashizaki Y. Expression profiling of transcriptional start sites. DNA microarrays 2008, Scion Publishing Ltd., Bloxham, UK. M. Schena (Ed.).
53. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., et al. Two-generation reproductive toxicity evaluation of dietary 17beta-estradiol (E2; CAS No 50-28-2) in CD-1 (Swiss) mice. Toxicol Sci 2008, 102:392-412.
54. Al-Hiyasat A.S., Darmani H., Elbetieha A.M. Effects of bisphenol A on adult male mouse fertility. Eur J Oral Sci 2002, 110:163-167.
55. Berger R.G., Foster W.G., deCatanzaro D. Bisphenol-A exposure during the period of blastocyst implantation alters uterine morphology and perturbs measures of estrogen and progesterone receptor expression in mice. Reprod Toxicol 2010, 30:393-400.
56. Duggan R.E., Weatherwax J.R. Dietary intake of pesticide chemicals. Calculated daily consumption of pesticides with foods are discussed and compared with currently accepted values. Science (New York, NY) 1967, 157:1006-1010.
57. Traina M.E., Rescia M., Urbani E., Mantovani A., Macri C., Ricciardi C., et al. Long-lasting effects of lindane on mouse spermatogenesis induced by in utero exposure. Reprod Toxicol 2003, 17:25-35.
58. Wittassek M., Koch H.M., Angerer J., Bruning T. Assessing exposure to phthalates - the human biomonitoring approach. Mol Nutr Food Res 2011, 55:7-31.
59. Calafat A.M., Needham L.L., Silva M.J., Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 2004, 113:e429-e434.
60. Plonait S.L., Nau H., Maier R.F., Wittfoht W., Obladen M. Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion 1993, 33:598-605.
61. Martin P.D.M., Keen P. The occurrence of zearalenone in raw and fermented products from Swaziland and Lesotho. J Int Soc Hum Anim Mycol (Sabouraudia) 1978, 16:15-22.
62. O'Donnell L., Robertson K.M., Jones M.E., Simpson E.R. Estrogen and spermatogenesis. Endocr Rev 2001, 22:289-318.
63. Muramatsu M., Inoue S. Estrogen receptors: how do they control reproductive and nonreproductive functions. Biochem Biophys Res Commun 2000, 270:1-10.
64. Pettersson K., Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001, 63:165-192.
65. Jobling S., Reynolds T., White R., Parker M.G., Sumpter J.P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 1995, 103:582-587.
66. Kuiper-Goodman T., Scott P.M., Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul Toxicol Pharmacol 1987, 7:253-306.
67. Hosoi I., Toyama Y., Maekawa M., Ito H., Yuasa S. Development of the blood-testis barrier in the mouse is delayed by neonatally administered diethylstilbestrol but not by beta-estradiol 3-benzoate. Andrologia 2002, 34:255-262.
68. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308:1466-1469.
69. Schneider S., Kaufmann W., Buesen R., van Ravenzwaay B. Vinclozolin - the lack of a transgenerational effect after oral maternal exposure during organogenesis. Reprod Toxicol 2008, 25:352-360.
70. Anway M.D., Rekow S.S., Skinner M.K. Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics 2008, 91:30-40.
71. Hajkova P., Erhardt S., Lane N., Haaf T., El-Maarri O., Reik W., et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002, 117:15-23.
72. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997, 236:313-322.
73. Turner T.T., Lysiak J.J. Oxidative stress: a common factor in testicular dysfunction. J Androl 2008, 29:488-498.
74. Gebauer F., Hentze M.W. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004, 5:827-835.
75. De Benedetti A., Graff J.R. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004, 23:3189-3199.
76. Lazaris-Karatzas A., Montine K.S., Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990, 345:544-547.
77. Graff J.R., Konicek B.W., Carter J.H., Marcusson E.G. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 2008, 68:631-634.
78. Parker R., Song H. The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 2004, 11:121-127.
79. Chen J., Chiang Y.C., Denis C.L. CCR4, a 3'-5' poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J 2002, 21:1414-1426.
80. Lufkin T., Lohnes D., Mark M., Dierich A., Gorry P., Gaub M.P., et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci U S A 1993, 90:7225-7229.
81. Azzouz N., Panasenko O.O., Deluen C., Hsieh J., Theiler G., Collart M.A. Specific roles for the Ccr4-Not complex subunits in expression of the genome. RNA 2009, 15:377-383.
82. Winkler G.S., Mulder K.W., Bardwell V.J., Kalkhoven E., Timmers H.T. Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. EMBO J 2006, 25:3089-3099.
83. Ogawa T., Ito C., Nakamura T., Tamura Y., Yamamoto T., Noda T., et al. Abnormal sperm morphology caused by defects in Sertoli cells of Cnot7 knockout mice. Arch Histol Cytol 2004, 67:307-314.
84. van Agthoven T., Veldscholte J., Smid M., van Agthoven T.L., Vreede L., Broertjes M., et al. Functional identification of genes causing estrogen independence of human breast cancer cells. Breast Cancer Res Treat 2009, 114:23-30.